Vivani Medical Inc reports results for the quarter ended in December - Earnings Summary

Reuters03-26

* Vivani Medical Inc reported a quarterly adjusted loss of 12 cents​​ per share for the quarter ended in December. The lone analyst forecast for the quarter was for a loss of 14 cents per share.

* Reported revenue was zero​; analysts expected zero.

* Vivani Medical Inc's reported EPS for the quarter was a loss of 12 cents​.

* The company reported a quarterly loss of $6.03 million.

* Vivani Medical Inc shares had risen by 88.2% this quarter.

FORECAST CHANGES

* The mean earnings estimate of analysts had fallen by about 7.7% in the last three months.​

* In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* Wall Street's median 12-month price target for Vivani Medical Inc is $8.00

This summary was machine generated from LSEG data March 26 at 02:34 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Dec. 31 2023 -0.14 -0.12 Beat

Sep. 30 2023 -0.13 -0.13 Met

Jun. 30 2023 -0.11 -0.13 Missed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment